Brief: Regeneus Enters Binding Merger Agreement With Cambium Medical Technologies
Feb 14 (Reuters) - Regeneus Ltd RGS.AX :
* REGENEUS ENTERS INTO BINDING MERGER AGREEMENT WITH CAMBIUM
MEDICAL TECHNOLOGIES
* WILL ACQUIRE 100% OF CMT SHARES
* CONSIDERATION FOR ACQUISITION OF SHARES WILL BE ISSUE OF
NEW
ORDINARY SHARES IN REGENEUS TO EXISTING CMT SHAREHOLDERS
Source text for Eikon: ID:nASXc8z61S
Further company coverage: RGS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology